Related news from
Fri, 26 Apr 2024 14:00:24 +0000	Analysts Estimate Immunome, Inc. (IMNM) to Report a Decline in Earnings: What to Look Out for Immunome (IMNM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Fri, 26 Apr 2024 11:58:00 +0000	Merus (MRUS) Moves 7.1% Higher: Will This Strength Last? Merus (MRUS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Thu, 25 Apr 2024 15:40:12 +0000	EXEL vs. REGN: Which Stock Is the Better Value Option? EXEL vs. REGN: Which Stock Is the Better Value Option?
Wed, 17 Apr 2024 14:20:28 +0000	Institutional investors in Exelixis, Inc. (NASDAQ:EXEL) lost 3.8% last week but have reaped the benefits of longer-term growth Key Insights Significantly high institutional ownership implies Exelixis' stock price is sensitive to their trading...
Tue, 16 Apr 2024 20:05:00 +0000	Exelixis to Release First Quarter 2024 Financial Results on Tuesday, April 30, 2024 ALAMEDA, Calif., April 16, 2024--Exelixis, Inc. (Nasdaq: EXEL) announced today that its first quarter 2024 financial results will be released on Tuesday, April 30, 2024 after the markets close. At 5:00 p.m. ET / 2:00 p.m. PT, Exelixis management will host a conference call and webcast to discuss the results and provide a general business update. Access to the event is available via the Internet from the company’s website.
Tue, 09 Apr 2024 15:40:12 +0000	EXEL or REGN: Which Is the Better Value Stock Right Now? EXEL vs. REGN: Which Stock Is the Better Value Option?
Thu, 28 Mar 2024 12:13:14 +0000	Insiders Are Dumping These 10 Healthcare Stocks In this article, we will take a detailed look at Insiders Are Dumping These 10 Healthcare Stocks. For a quick overview of such stocks, read our article Insiders Are Dumping These 5 Healthcare Stocks. Healthcare-focused investors were nervous when 2024 started, since election years usually do not bode well for the healthcare industry amid policy-related uncertainties. But healthcare stocks […]
Sat, 23 Mar 2024 09:06:00 +0000	4 Magnificent Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market Phenomenal deals can still be found, even with the Nasdaq Composite climbing to a new all-time high.
Thu, 21 Mar 2024 12:21:38 +0000	Exelixis, Inc.'s (NASDAQ:EXEL) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue? Exelixis' (NASDAQ:EXEL) stock is up by a considerable 16% over the past month. However, we decided to pay attention to...
Sun, 17 Mar 2024 12:50:16 +0000	30 Biggest Biotechnology Companies in the World In this article, we will be taking a look at the 30 biggest biotechnology companies in the world. If you do not want to learn about the global biotech market, head straight to the 5 Biggest Biotechnology Companies in the World. In the ever-evolving landscape of biotechnology, several companies like Novo Nordisk, Regeneron, and United […]
Wed, 13 Mar 2024 15:30:14 +0000	Why Is Immunovant, Inc. (IMVT) Down 14.7% Since Last Earnings Report? Immunovant, Inc. (IMVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Mon, 11 Mar 2024 14:36:00 +0000	The Zacks Analyst Blog Highlights Legend Biotech, Exact Sciences, Exelixis, Ascendis Pharma and MorphoSys Legend Biotech, Exact Sciences, Exelixis, Ascendis Pharma and MorphoSys are part of the Zacks top Analyst Blog.
Fri, 08 Mar 2024 14:38:44 +0000	10 Biotech Stocks with Huge Potential In this article, we will take a look at the 10 biotech stocks with huge potential. To skip our analysis of the recent trends, and market activity, you can go directly to see the 5 Biotech Stocks with Huge Potential. Recent developments, technological as well as optimism related to interest rate reductions, have led to […]
Fri, 08 Mar 2024 13:15:00 +0000	2 Biotech Stocks to Buy Hand Over Fist in March These stocks are worth buying in most months of the year.
Thu, 07 Mar 2024 16:31:04 +0000	Why Is Exelixis (EXEL) Up 10.9% Since Last Earnings Report? Exelixis (EXEL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Thu, 07 Mar 2024 15:08:53 +0000	10 Mid-Cap Stocks with Insider Purchases In this article, we will take a detailed look at the 10 Mid-Cap Stocks with Insider Purchases. For a quick overview of such stocks, read our article 5 Mid-Cap Stocks with Insider Purchases. Investors are yet again in a wait-and-see mode ahead of key jobs and inflation numbers, but the overall sentiment in the market is positive, helped […]
Wed, 06 Mar 2024 21:45:00 +0000	3 Cutting-Edge Biotech Stocks Sitting on the Brink of Success Biotech stocks have always been high-risk and high-reward, with the futures and fortunes of companies often decided with a single successful drug trial or Federal Drug Administration (FDA) approval. The right company can yield extravagant returns for the lucky or prudent investor. However, choosing the wrong ones can lead to losses just as significant as the potential wins. Therefore, due diligence is important. A company announcing that it is developing a cure for cancer, MS, Huntington’s, or H
Sat, 02 Mar 2024 10:06:00 +0000	4 Thrilling Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market The growth-driven Nasdaq Composite has entered a new bull market, but plain-as-day deals can still be found.
Fri, 01 Mar 2024 14:15:09 +0000	ANI Pharmaceuticals, Inc. (ANIP) Hit a 52 Week High, Can the Run Continue? ANI (ANIP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Thu, 29 Feb 2024 19:57:04 +0000	Is Now The Time To Put Exelixis (NASDAQ:EXEL) On Your Watchlist? Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...